pharmacokinetic characteristics
Showing 1 - 25 of >10,000
Healthy Subjects Trial in Shanghai (JYP0061, )
Completed
- Healthy Subjects
- JYP0061
- placebo
-
Shanghai, Shanghai, ChinaShanghai Xuhui District Central Hospital
Nov 16, 2023
Hyperammonemia Trial in Changchun (TNP-2092 capsules, TNP-2092 capsules)
Completed
- Hyperammonemia
- TNP-2092 placebo capsules
- TNP-2092 capsules
-
Changchun, Jilin, ChinaThe First Hospital of Jilin University
Nov 13, 2023
Healthy Subjects Trial in Cheongju-si (DW6014)
Completed
- Healthy Subjects
-
Cheongju-si, Korea, Republic ofChungbuk National University Hospital
Apr 10, 2023
DW6014 Trial in Cheongju-si (DW6014)
Not yet recruiting
- DW6014
-
Cheongju-si, Korea, Republic ofChungbuk National University Hospital
Apr 10, 2023
Healthy Subject Trial in Seoul (Ursodeoxycholic Acid 250 Mg Oral Tablet)
Completed
- Healthy Subject
- Ursodeoxycholic Acid 250 Mg Oral Tablet
-
Seoul, Korea, Republic Of, Korea, Democratic People's Republic ofKyung Hee University Medical Hospital
Apr 16, 2023
FDC, Diabetes, Type 2 Trial in Cheongju-si (DWC202213, DWJ1563, DWP16001)
Recruiting
- FDC
- Diabetes Mellitus, Type 2
- DWC202213
- +2 more
-
Cheongju-si, Seowon-gu, Korea, Republic ofChungbuk National University Hospital
Feb 10, 2023
Infertility Trial in Chengdu, (GenSci094)
Recruiting
- Infertility
-
Chengdu,, Sichuan, ChinaChengdu Xinhua Hospital, affiliated with Sichuan North Medical C
Oct 18, 2023
Healthy Volunteers Trial (DWP16001 Drug A, DWP16001 Drug C)
Not yet recruiting
- Healthy Volunteers
- DWP16001 Drug A
- DWP16001 Drug C
- (no location specified)
Jul 19, 2022
Serous Ovarian Cancer, Advanced Ovarian Cancer Trial (SC0191, Gemcitabine, Paclitaxel)
Not yet recruiting
- Serous Ovarian Cancer
- Advanced Ovarian Cancer
- SC0191
- +2 more
- (no location specified)
Sep 20, 2023
Chronic HBV Infection Trial in Xuzhou (PA1010)
Completed
- Chronic HBV Infection
-
Xuzhou, Jiangsu, ChinaAffiliated Hospital of Xuzhou Medical University
Jul 18, 2022
Healthy Subjects Trial in Cheongju-si (DW6013)
Completed
- Healthy Subjects
-
Cheongju-si, Korea, Republic ofChungbuk National University Hospital
May 16, 2023
Healthy Subjects Trial in Cheongju-si (DW6013)
Completed
- Healthy Subjects
-
Cheongju-si, Korea, Republic ofChungbuk National University Hospital
May 16, 2023
Hypertension Trial (CKD-341, D958)
Not yet recruiting
- Hypertension
- CKD-341, D958
- (no location specified)
Jun 18, 2023
Advanced Solid Tumors Trial in Changchun (BAT8006 for Injection)
Recruiting
- Advanced Solid Tumors
- BAT8006 for Injection
-
Changchun, Jilin, ChinaThe First Hospital of Jilin University
Jul 26, 2022
Solid Tumor Trial (Disitamab vedotin)
Not yet recruiting
- Solid Tumor
- Disitamab vedotin
- (no location specified)
Jul 10, 2023
Cadmium Exposure Trial in Changsha (GMDTC for injection, Normal saline)
Recruiting
- Cadmium Exposure
- GMDTC for injection
- Normal saline
-
Changsha, Hunan, ChinaHunan Occupational Disease Prevention and Control Institute
Jun 9, 2023
Heathly Subjects Trial in Seoul (Single subcutaneous administration and Blood collection, Single subcutaneous administration and
Recruiting
- Heathly Subjects
- Single subcutaneous administration and Blood collection
- +2 more
-
Seoul, Korea, Republic ofSeoul National University
Oct 5, 2022
Influenza, Human Trial in Shanghai (ZX-7101A 80mg)
Recruiting
- Influenza, Human
- ZX-7101A 80mg
-
Shanghai, ChinaShuguang Hospital, Shanghai University of Traditional Chinese Me
Feb 2, 2023